Goutham Sunny

3.8K posts

Goutham Sunny banner
Goutham Sunny

Goutham Sunny

@medoncodoc

Asst Prof, Medical Oncology @GCRI_1972 @offcmcvellore alumni #pantumor 🧬🌐, Academic account, #medtwitter. Follow @gsrocks007 for personal account.

India Katılım Aralık 2009
487 Takip Edilen1.1K Takipçiler
Goutham Sunny retweetledi
WabiSabi
WabiSabi@Geeky_Foodie·
So now even taxanes supply is under threat. If the authorities can’t ensure that stocks of non expensive essential life saving cancer drugs are restored, request them to atleast issue an official legal order that absolves medical oncologists from the legal liability of inferior treatments and outcomes thanks to national shortage of these drugs, coz while we would very much like saving lives, when that is not facilitated by the Government and the global situation, we would very much like to atleast save our @$$! @MoHFW_INDIA @PMOIndia @JPNadda
WabiSabi@Geeky_Foodie

In oncology we say one size doesn’t fit all, but if there are any drugs that work in almost all cancers, they have to be platinum drugs especially Cisplatin and Carboplatin. The simplest, effective and cheapest drugs that have no replacement in several cancers are out of stock in most hospitals in India, leaving patients and families to suffer with no treatments even in curable cancers. The global supply chain has been massively impacted, so are the import rates and manufacturing rates. While capping prices of drugs is a welcome move, flexibility that is reviewed dynamically is the need of the hour, a 50% rise in capped price of a 200 rupees drug that is life saving should be accommodated as the cost of lives lost is going to be much more. Request @narendramodi @PMOIndia @JPNadda @MoHFW_INDIA @AmitShahOffice to resolve the situation ASAP

English
3
9
23
2.1K
Goutham Sunny retweetledi
WabiSabi
WabiSabi@Geeky_Foodie·
In oncology we say one size doesn’t fit all, but if there are any drugs that work in almost all cancers, they have to be platinum drugs especially Cisplatin and Carboplatin. The simplest, effective and cheapest drugs that have no replacement in several cancers are out of stock in most hospitals in India, leaving patients and families to suffer with no treatments even in curable cancers. The global supply chain has been massively impacted, so are the import rates and manufacturing rates. While capping prices of drugs is a welcome move, flexibility that is reviewed dynamically is the need of the hour, a 50% rise in capped price of a 200 rupees drug that is life saving should be accommodated as the cost of lives lost is going to be much more. Request @narendramodi @PMOIndia @JPNadda @MoHFW_INDIA @AmitShahOffice to resolve the situation ASAP
WabiSabi tweet media
English
8
34
85
8.8K
Goutham Sunny retweetledi
Goutham Sunny retweetledi
Dr. Foxpaws Fauxpas
Dr. Foxpaws Fauxpas@foxpaws_onco·
Reviewing 1L options in advanced #HCC Atezo Bev still has the strongest signal and longest followup - across multiple subsets. ✅ AFP>400 ✅ Vp4 portal invasion ✅ Viral HCC ❓MAFLD ❓ Fibrolamellar TKIs with signals - Sora, Lenva, Cabo, Regora @OncoDailyGI @oncodaily #cancer
Dr. Foxpaws Fauxpas tweet mediaDr. Foxpaws Fauxpas tweet mediaDr. Foxpaws Fauxpas tweet mediaDr. Foxpaws Fauxpas tweet media
English
2
23
54
2.7K
Goutham Sunny retweetledi
Yakup Ergün
Yakup Ergün@dr_yakupergun·
One of the most notable studies from #AACR26: Daraxonrasib + gem/nab-paclitaxel shows a strong early signal in 1L mPDAC. ORR 58% DCR 90% 6-month PFS 84%!! Things are finally moving in pancreatic cancer👇 aacrjournals.org/cancerres/arti…
Yakup Ergün tweet media
English
3
40
128
12.4K
Goutham Sunny retweetledi
Pramesh CS
Pramesh CS@cspramesh·
Never forget this. Time is finite... Family always comes first. Courtesy @jenna_taglienti
Pramesh CS tweet media
English
1
45
146
7.8K
Goutham Sunny retweetledi
akhilrk1989
akhilrk1989@akhilrk1989·
Excited to share our new publication in Expert Opinion on Investigational Drugs: We discuss the role of CDK8/19 in AML transcription and early clinical data on romaciclib, including promising combinations with venetoclax in relapsed/refractory disease. tandfonline.com/doi/full/10.10…
akhilrk1989 tweet media
English
1
2
11
576
Goutham Sunny retweetledi
Dr. Foxpaws Fauxpas
Dr. Foxpaws Fauxpas@foxpaws_onco·
Let's review the mech of Gonadotoxicity in #lymphoma Rx - ROS+direct damage ❌ Worst culprits - Alkylators - Procarbazine & cyclophos 👀 Jury's out on long term data - relatively safe - BV, Nivo, Pembro ⚠️ Teratogenicity - Etopo, Len #medtwitter #oncology #cancer #fertility
Dr. Foxpaws Fauxpas tweet media
English
0
3
8
634
Goutham Sunny retweetledi
Nieves Martinez Lago MD PhD
Nieves Martinez Lago MD PhD@DraMartinezLago·
🧬✨ Just published: ESMO Guidelines 2026 in mCRC 📊 Molecular-driven algorithm consolidated 🧪 Mandatory profiling → RAS/BRAF, MSI, HER2 ±NGS 🎯 1L by biology → MSI-H: ICI | RAS wt left: anti-EGFR 💊 3L+ → FTD/TPI + BEV preferred 💥 Precision + sequencing redefine SoC 🔗 annalsofoncology.org/action/showPdf… @OncoAlert
Nieves Martinez Lago MD PhD tweet mediaNieves Martinez Lago MD PhD tweet mediaNieves Martinez Lago MD PhD tweet mediaNieves Martinez Lago MD PhD tweet media
English
1
34
62
4.2K
Goutham Sunny retweetledi
Yakup Ergün
Yakup Ergün@dr_yakupergun·
Algorithm for Systemic Therapy in Early HR+/HER2- Breast Cancer (Recommendations in gray areas reflect my own clinical judgment— eg. olaparib and CDK4/6 sequence)
Yakup Ergün tweet media
English
1
90
221
28.6K
Anil Kumar Subbarao
Anil Kumar Subbarao@DarwinAnil·
Honored to receive the Rising Star in Asia Award at JSMO 2026. I express my heartfelt gratitude to my mentor, @todrashish, for his constant guidance, also grateful to @OffCMCVellore for providing the opportunities that made this possible. @JSMO_official #JSMORISA2026
Anil Kumar Subbarao tweet mediaAnil Kumar Subbarao tweet mediaAnil Kumar Subbarao tweet media
Yokohama-shi Nishi, Kanagawa 🇯🇵 English
3
0
16
1K
Goutham Sunny retweetledi
Wungki Park, MD MS
Wungki Park, MD MS@CentralParkWMD·
1/n Setidegrasib the first-in-human, first-in-class, KRAS G12D-targeted protein degrader #TPD Our KRAS G12D degrader study is now published in the New England Journal of Medicine @NEJM nejm.org/doi/full/10.10… A new way to target KRAS G12D - one of the most common oncogenic drivers across cancers.
Wungki Park, MD MS tweet media
Guadalupe, AZ 🇺🇸 English
20
99
293
44.9K
Goutham Sunny retweetledi
Nieves Martinez Lago MD PhD
Nieves Martinez Lago MD PhD@DraMartinezLago·
💉 Pegfilgrastim timing matters 📊 Phase III RCT (breast cancer) ⏱️ 72h vs 24–48h post-CT 📉 Bone pain (AUC): 6.05 vs 12.7–14.2 🔥 📉 Severe pain: 22.6% vs ~60% ⚖️ No ↑ neutropenia or FN 💡 Delaying to 72h may reduce toxicity without compromising efficacy 🔗 doi.org/10.7326/ANNALS… @OncoAlert
Nieves Martinez Lago MD PhD tweet media
English
3
58
126
9.8K
Goutham Sunny retweetledi
Dr. Foxpaws Fauxpas
Dr. Foxpaws Fauxpas@foxpaws_onco·
Let's review #TNT Total Neoadjuvant Treatment and Organ Preservation in #Rectal #Cancers. 1. PRODIGE23 - Induction CT + CRT 2. PROSPECT - No RT & Mid/upper only 3. OPRA - Induction CRT CT Ph2 4. OPERA - Contact Brachy Boost 5. MORPHEUS - HDR BT boost #crcsm #Oncology
Dr. Foxpaws Fauxpas tweet media
English
4
132
333
21.6K